Adam S Grossman Adma Biologics, Inc. (ADMA) insider trading activity

Adam S Grossman is President,CEO, and Interim CFO of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 2.06 Million shares of ADMA, which is worth approximately $23.5 Million. The most recent transaction as insider was on Sep 30, 2022, when has been sold 101,315 shares (Common Stock) at a price of $2.43 per share, resulting in proceeds of $246,195. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.06M

22.32% 3M change

18.36% 12M change

Total Value Held $23.5 Million

Adam S Grossman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2022	SELL Payment of exercise price or tax liability	$246,195 $2.43 p/Share	101,315 Reduced 4.42%	2,188,725 Common Stock
May 11 2022	SELL Payment of exercise price or tax liability	$100,106 $1.43 p/Share	70,004 Reduced 2.97%	2,290,040 Common Stock
Mar 23 2022	SELL Payment of exercise price or tax liability	$73,787 $1.46 p/Share	50,539 Reduced 2.1%	2,360,044 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	-	300,000 Added 11.07%	2,410,583 Common Stock
Oct 25 2021	BUY Open market or private purchase	$100,000 $1.0 p/Share	100,000 Added 4.47%	2,137,616 Common Stock
Sep 29 2021	BUY Grant, award, or other acquisition	-	1,650,000 Added 44.74%	2,037,616 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	221,447 Added 35.78%	397,545 Common Stock

ASG

Adam S Grossman

President,CEO, and Interim CFO

Ramsey, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Value

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA

Account